$1.66 Billion is the total value of Vivo Capital, LLC's 55 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 31.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TIL | Instil Bio Inc | $213,649,000 | -4.3% | 12,486,787 | 0.0% | 12.88% | +28.5% | |
| HRMY | Harmony Biosciences Holdings Inc | $208,268,000 | +11.2% | 4,884,341 | 0.0% | 12.56% | +49.4% | |
| NFH | New Frontier Health Corp | $163,878,000 | +2.0% | 14,300,000 | 0.0% | 9.88% | +37.0% | |
| ISEE | Buy | Iveric Bio Inc | $105,183,000 | +8.6% | 6,290,827 | +5.4% | 6.34% | +45.8% |
| ALXO | ALX Oncology Holdings Inc | $90,689,000 | -70.9% | 4,220,048 | 0.0% | 5.47% | -60.9% | |
| TARS | Tarsus Pharmaceuticals Inc | $67,215,000 | +4.4% | 2,987,331 | 0.0% | 4.05% | +40.2% | |
| AMRS | Amyris, Inc | $62,984,000 | -60.6% | 11,642,195 | 0.0% | 3.80% | -47.1% | |
| ASND | Sell | Ascendis Pharma A/Ssponsored adr | $59,530,000 | -50.9% | 442,502 | -41.8% | 3.59% | -34.0% |
| ALGS | Aligos Therapeutics Inc | $42,103,000 | -23.5% | 3,547,030 | 0.0% | 2.54% | +2.8% | |
| SRRA | Sierra Oncology, Inc | $41,677,000 | -0.8% | 1,917,074 | 0.0% | 2.51% | +33.2% | |
| GTH | Genetron Holdings Ltdads | $38,673,000 | -56.0% | 6,339,860 | 0.0% | 2.33% | -40.9% | |
| SVA | Sinovac Biotech Ltd. | $38,173,000 | 0.0% | 5,900,000 | 0.0% | 2.30% | +34.3% | |
| New | Ventyx Biosciences Inc | $35,575,000 | – | 1,791,275 | +100.0% | 2.14% | – | |
| Sell | Aadi Bioscience Inc | $31,477,000 | -24.9% | 1,303,390 | -8.7% | 1.90% | +0.9% | |
| VRDN | Viridian Therapeutics Inc | $25,701,000 | +20.2% | 1,300,000 | 0.0% | 1.55% | +61.5% | |
| IMPL | Impel NeuroPharma Inc | $24,896,000 | -29.1% | 2,884,789 | 0.0% | 1.50% | -4.9% | |
| AVDL | Avadel Pharmaceuticals PLCadr | $23,732,000 | -17.6% | 2,937,093 | 0.0% | 1.43% | +10.8% | |
| KALV | Sell | KalVista Pharmaceuticals Inc. | $20,289,000 | -29.2% | 1,533,559 | -6.6% | 1.22% | -4.9% |
| RLMD | New | Relmada Therapeutics Inc | $19,879,000 | – | 882,352 | +100.0% | 1.20% | – |
| New | IO Biotech Inc | $19,299,000 | – | 3,015,545 | +100.0% | 1.16% | – | |
| BOLT | Bolt Therapeutics Inc | $18,969,000 | -61.3% | 3,871,291 | 0.0% | 1.14% | -48.0% | |
| TERN | Terns Pharmaceuticals Inc | $18,913,000 | -32.2% | 2,675,133 | 0.0% | 1.14% | -8.9% | |
| CLDX | Celldex Therapeutics Inc | $18,719,000 | -28.4% | 484,453 | 0.0% | 1.13% | -3.8% | |
| VRNA | Verona Pharma PLCads | $18,479,000 | +22.6% | 2,749,918 | 0.0% | 1.11% | +64.5% | |
| COGT | Buy | Cogent Biosciences Inc | $16,482,000 | +37.9% | 1,920,941 | +35.2% | 0.99% | +85.1% |
| OLMA | Buy | Olema Pharmaceuticals Inc | $15,814,000 | -53.7% | 1,689,515 | +36.4% | 0.95% | -37.8% |
| KDNY | Chinook Therapeutics Inc | $14,225,000 | +27.8% | 872,151 | 0.0% | 0.86% | +71.6% | |
| MRUS | Merus NV | $14,056,000 | +44.5% | 442,000 | 0.0% | 0.85% | +94.1% | |
| ACRS | Sell | Aclaris Therapeutics, Inc. | $13,391,000 | -20.9% | 920,982 | -2.1% | 0.81% | +6.2% |
| Sera Prognostics Inc | $12,751,000 | -38.2% | 1,856,011 | 0.0% | 0.77% | -17.0% | ||
| CDXS | Codexis, Inc | $12,137,000 | +34.4% | 388,144 | 0.0% | 0.73% | +80.7% | |
| New | Minerva Surgical Inc | $11,389,000 | – | 2,215,667 | +100.0% | 0.69% | – | |
| LEGN | Sell | Legend Biotech Corp Sponsoredsponsored ads | $11,390,000 | -53.9% | 244,375 | -50.0% | 0.69% | -38.1% |
| DSGN | Design Therapeutics | $11,369,000 | +45.8% | 530,991 | 0.0% | 0.69% | +96.0% | |
| MREO | Mereo Biopharma Group PLCads | $11,052,000 | -33.9% | 6,907,189 | 0.0% | 0.67% | -11.3% | |
| ZLAB | Zai Lab Ltd ADRadr | $10,999,000 | -40.4% | 174,999 | 0.0% | 0.66% | -19.9% | |
| EPIX | Sell | Essa Pharma Inc | $10,566,000 | +25.1% | 744,058 | -29.5% | 0.64% | +68.1% |
| ARWR | Arrowhead Pharmaceuticals Inc | $9,110,000 | +6.2% | 137,411 | 0.0% | 0.55% | +42.6% | |
| Sell | Dice Therapeutics Inc | $8,258,000 | -38.5% | 326,272 | -20.4% | 0.50% | -17.4% | |
| BLU | New | Bellus Health Inc | $8,188,000 | – | 1,017,152 | +100.0% | 0.49% | – |
| NKTX | Nkarta Inc | $7,863,000 | -44.8% | 512,225 | 0.0% | 0.47% | -25.9% | |
| DYN | Dyne Therapeutics Inc | $6,868,000 | -26.8% | 577,642 | 0.0% | 0.41% | -1.7% | |
| CMPX | New | Compass Therapeutics Inc | $6,340,000 | – | 2,000,000 | +100.0% | 0.38% | – |
| GRCL | Gracell Biotechnologies Incsponsored ads | $5,807,000 | -56.4% | 961,359 | 0.0% | 0.35% | -41.6% | |
| IOVA | New | Iovance Biotherapeutics Inc | $5,746,000 | – | 301,000 | +100.0% | 0.35% | – |
| STSA | Satsuma Pharmaceuticals Inc | $5,546,000 | -3.4% | 1,232,394 | 0.0% | 0.33% | +29.5% | |
| ZYME | Zymeworks Inc | $4,689,000 | -43.6% | 286,064 | 0.0% | 0.28% | -24.1% | |
| LRMR | Larimar Therapeutics Inc | $4,314,000 | -6.4% | 399,830 | 0.0% | 0.26% | +25.6% | |
| ASLN | Aslan Pharmaceuticals Ltdads | $3,182,000 | -37.1% | 2,840,909 | 0.0% | 0.19% | -15.4% | |
| FIXX | Homology Medicines, Inc. | $3,105,000 | -53.8% | 853,143 | 0.0% | 0.19% | -37.9% | |
| ELEV | Buy | Elevation Oncology Inc | $2,991,000 | -22.7% | 496,844 | +0.0% | 0.18% | +3.4% |
| ZGNX | Zogenix Inc | $1,706,000 | +7.0% | 105,000 | 0.0% | 0.10% | +43.1% | |
| DTIL | Precision Biosciences Inc | $1,038,000 | -35.9% | 140,255 | 0.0% | 0.06% | -13.7% | |
| MTCR | Metacrine Inc | $99,000 | -80.3% | 146,426 | 0.0% | 0.01% | -73.9% | |
| EIGR | Sell | Eiger BioPharmaceuticals Inc | $22,000 | -99.3% | 4,166 | -99.1% | 0.00% | -99.3% |
| TCDA | Exit | Tricida, Inc. | $0 | – | -167,863 | -100.0% | -0.04% | – |
| TXG | Exit | 10X Genomics Inc | $0 | – | -14,798 | -100.0% | -0.10% | – |
| ORTX | Exit | Orchard Therapeutics plcads | $0 | – | -1,325,736 | -100.0% | -0.14% | – |
| PASG | Exit | Passage Bio Inc | $0 | – | -539,263 | -100.0% | -0.24% | – |
| SNDX | Exit | Syndax Pharmaceuticals Inc | $0 | – | -320,000 | -100.0% | -0.28% | – |
| VALN | Exit | Valneva SEsponsored ads | $0 | – | -200,000 | -100.0% | -0.28% | – |
| KURA | Exit | Kura Oncology Inc | $0 | – | -525,262 | -100.0% | -0.44% | – |
| ARQT | Exit | Arcutis Biotherapeutics Inc | $0 | – | -433,585 | -100.0% | -0.46% | – |
| CRNX | Exit | Crinetics Pharmaceuticals Inc | $0 | – | -517,280 | -100.0% | -0.49% | – |
| AUPH | Exit | Aurinia Pharmaceuticals Inc. | $0 | – | -500,732 | -100.0% | -0.50% | – |
| CRIS | Exit | Curis Inc | $0 | – | -1,553,500 | -100.0% | -0.55% | – |
| KDMN | Exit | Kadmon Holdings Inc | $0 | – | -4,283,014 | -100.0% | -1.68% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 29 | Q3 2023 | 33.5% |
| CODEXIS INC | 29 | Q3 2023 | 8.0% |
| ASCENDIS PHARMA A/S | 25 | Q3 2022 | 24.0% |
| KALVISTA PHARMACEUTICALS INC | 25 | Q3 2023 | 3.9% |
| Verona Pharma PLC ADR | 24 | Q3 2023 | 7.6% |
| AMYRIS INC | 23 | Q3 2023 | 8.8% |
| EIGER BIOPHARMACEUTICALS INC | 23 | Q1 2022 | 8.7% |
| Zai Lab Ltd ADR | 22 | Q3 2023 | 1.8% |
| Arrowhead Pharmaceuticals Inc | 21 | Q3 2023 | 6.9% |
| HOMOLOGY MEDICINES INC | 21 | Q3 2023 | 3.7% |
View Vivo Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SINOVAC BIOTECH LTDSold out | August 27, 2018 | 0 | 0.0% |
View Vivo Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-22 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Vivo Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.